Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Cancer Cell International

Fig. 4

From: Histone variant MacroH2A1 is downregulated in prostate cancer and influences malignant cell phenotype

Fig. 4

Knockdown of MacroH2A1 in DU145 cell line. a Illustrative images of MacroH2A1 isoforms protein after MacroH2A1 knockdown, carried out by si-RNA, in DU145 prostate cancer cell line at 72 h’ post-transfection, obtained by Western-Blot. b Fold variation of MacroH2A1.1 and MacroH2A1.2 protein levels in MacroH2A1-knockdown DU145 cell line, in comparison to si-scramble DU145 cell line (mean ± SD, n = 3), assessed by western-blot. Unpaired t test: *p < 0.05. Impact of MacroH2A1 knockdown in cell viability (c) and apoptosis levels (d) after 72 h (mean ± SD, n = 3). Mann–Whitney U-test: *p < 0.05, ***p < 0.001

Back to article page